Despite the ground-breaking benefits and scientific advancements in Chimeric Antigen Receptor T-cell (CAR-T) cell therapy, there are significant challenges for CAR-T clinical trials in diseases outside of cancer. These barriers include lack of awareness and knowledge, apprehension and hesitation amongst patients and healthcare providers, logistical and financial concerns, and inequitable access to this new therapy. This project aims to address these challenges by evaluating new resources to enhance access to participation in CAR-T clinical trials.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Saira Sheikh
Thurston Arthritis Research Center
Clinical or Medical
Interventional
Chronic Conditions
25-2752